¼¼°èÀÇ ½Ã¸°Áö ÆßÇÁ ½ÃÀå
Syringe Pumps
»óǰÄÚµå : 1793874
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 363 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License)
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)


Çѱ۸ñÂ÷

¼¼°èÀÇ ½Ã¸°Áö ÆßÇÁ ½ÃÀåÀº 2030³â±îÁö 326¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 240¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½Ã¸°Áö ÆßÇÁ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 5.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 326¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÁÖÀÔ ÆßÇÁ´Â CAGR 6.2%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 214¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÈíÀÎ ÆßÇÁ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 3.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 65¾ï ´Þ·¯, Áß±¹Àº CAGR 8.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Ã¸°Áö ÆßÇÁ ½ÃÀåÀº 2024³â¿¡ 65¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 8.5%¸¦ °ßÀÎÇϸç, 2030³â¿¡´Â ½ÃÀå ±Ô¸ð°¡ 66¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.5%¿Í 5.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½Ã¸°Áö ÆßÇÁ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÁÖ»ç±â ÆßÇÁ°¡ ÀÇ·á ÇöÀå¿¡¼­ Çʼö ºÒ°¡°áÇÑ Á¸Àç°¡ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÁÖ»ç±â ÆßÇÁ´Â ¼Ò·®ÀÇ ¼öºÐ, ¾à¹°, ¿µ¾çºÐÀ» ÀÏÁ¤ ½Ã°£ µ¿¾È Á¦¾îÇϸ鼭 °ø±ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â Á¤¹ÐÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ÀåºñµéÀº ÁßȯÀÚ½Ç, ½Å»ý¾Æ ¹× ¼Ò¾Æ°ú, Á¾¾çº´µ¿, ÅëÁõ°ü¸® ÇÁ·ÎÅäÄÝ¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀϰüµÇ°í ÇÁ·Î±×·¥ °¡´ÉÇÑ ¾à¹°Àü´ÞÀ» Á¦°øÇÒ ¼ö ÀÖÀ¸¹Ç·Î °­·ÂÇÑ ¾à¹°À̳ª Ä¡·á ¹üÀ§°¡ Á¼Àº ¾à¹°À» Æ÷ÇÔÇÑ °íÀ§Ç豺 Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ°í º´¿ø Ä¡·á°¡ Á¡Á¡ ´õ ÇÁ·ÎÅäÄÝ Áß½ÉÀ̵ʿ¡ µû¶ó ÁÖ»ç±â ÆßÇÁ´Â ´õ ³ÐÀº ¹üÀ§ÀÇ Áø·á°ú¿¡¼­ äÅõǰí ÀÖ½À´Ï´Ù. Ç×»ýÁ¦ Á¤¸ÆÅõ¿©, È­Çпä¹ý, ¸¶Ãë µî ±× À¯¿ë¼ºÀº Çö´ë ¼ö¾×¿ä¹ýÀÇ ±âÃʰ¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü·¡ Ä¡·á ¹× ÀçÅà ¼ö¾× ¼­ºñ½º·ÎÀÇ ÀüȯÀÌ ÁøÇàµÊ¿¡ µû¶ó Ä¡·áÀÇ Á¤È®¼ºÀ» À¯ÁöÇϸ鼭 ȯÀÚÀÇ À̵¿¼ºÀ» º¸ÀåÇÒ ¼ö ÀÖ´Â ÀÛ°í ÈÞ´ë °¡´ÉÇÑ ÁÖ»ç±â ÆßÇÁ ¸ðµ¨¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Çõ½ÅÀº ÁÖ»ç±â ÆßÇÁ ½Ã½ºÅÛÀÇ ¾ÈÀü¼º°ú Áö´ÉÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

ÃֽŠÁÖ»ç±â ÆßÇÁ¿¡´Â Åõ¿© ¿À·ù °¨¼Ò ½Ã½ºÅÛ(DERS), º¼·¯½º ¹æÁö ±â´É, ¿¡¾î ÀζóÀÎ °¨Áö, ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ Àá±Ý ÀåÄ¡ µî ÷´Ü ¾ÈÀü ±â´ÉÀÌ Å¾ÀçµÇ¾î ÀÖ½À´Ï´Ù. º´¿ø ÀüÀÚÀǹ«±â·Ï(EMR) ¹× ¼ö¾× °ü¸® Ç÷§Æû°úÀÇ ÅëÇÕÀ» ÅëÇØ Æó¼â ·çÇÁ Åõ¾à °ü¸®°¡ °¡´ÉÇØÁ® ÃßÀû¼ºÀÌ Çâ»óµÇ°í ÀÎÀû ¿À·ù¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

¹«¼± ¿¬°á°ú ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º¸¦ ÅëÇØ »ç¿ëÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ë ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¾à±¹ µ¥ÀÌÅͺ£À̽º ¹× ÀÓ»ó ÇÁ·ÎÅäÄݰú ÅëÇÕ °¡´ÉÇÑ ½º¸¶Æ® ÆßÇÁ´Â Á¤È®ÇÑ ¿ë·®À» º¸ÀåÇÏ°í ¾à¹° ºÎÀÛ¿ëÀ» ÁÙÀ̱â À§ÇØ µµÀԵǰí ÀÖ½À´Ï´Ù. ±ä±ÞÇÑ È¯°æ¿¡¼­ ÁÖ»ç±â ÆßÇÁ´Â ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ¿¬µ¿ÇÏ¿© ½Ç½Ã°£ ÁÖÀÔ Çǵå¹é ¹× ÀÚµ¿ ¾Ë¶÷À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû °³¼±À¸·Î ÁÖ»ç±â ÆßÇÁ´Â ´õ¿í Áö´ÉÈ­µÉ »Ó¸¸ ¾Æ´Ï¶ó ÀÓ»ó ¾ÈÀü ¿öÅ©Ç÷οìÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ»ç±â ÆßÇÁÀÇ »ç¿ëÀº ±âÁ¸ ȯ°æÀ» ³Ñ¾î ¾îµð¿¡¼­ È®´ëµÇ°í Àִ°¡?

ÁÖ»ç±â ÆßÇÁ´Â º´¿øÀ̳ª Áø·á¼Ò»Ó¸¸ ¾Æ´Ï¶ó ¿Ü·¡ ¼ö¾×¼¾ÅÍ, ÀÀ±Þ ÀÌ¼Û ¼­ºñ½º, ÀçÅà Äɾî ÇÁ·Î±×·¥ µî¿¡¼­µµ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿ÏÈ­Ä¡·á, È£¸£¸ó Ä¡·á, Ç×±ÕÁ¦ ÁÖÀÔ µî Àå±â Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚµéÀº Áý¿¡¼­ Àü¹®°¡ÀÇ ¸ð´ÏÅ͸µ ÇÏ¿¡ ÈÞ´ë¿ë ÆßÇÁ¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù.

¼öÀÇÇÐ, Çмú¿¬±¸½Ç, »ý¸í°øÇÐ ½Ã¼³¿¡¼­µµ ½ÇÇè ¹× ¾à¹°Àü´Þ Å×½ºÆ®¿¡¼­ Á¤È®ÇÑ À¯Ã¼ Á¦¾î¸¦ À§ÇØ ÁÖ»ç±â ÆßÇÁ¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹¿¡¼­´Â Á¤ºÎ¿Í NGO°¡ ÁÖ»ç±â ÆßÇÁ¸¦ À̵¿ Áø·á¼Ò³ª ³óÃÌ º´¿ø¿¡ ¹èÄ¡ÇÏ¿© »ê¸ð °ü¸®, ¾î¸°ÀÌ ¿¹¹æÁ¢Á¾, °¨¿°¼º Áúȯ Ä¡·á¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÇÑ ¿ëµµ¿¡ µû¶ó ´ë·® »ý»êǰ°ú Ư¼ö Á¦Ç° ¸ðµÎ¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÖ´Â ´ÙÂ÷¿øÀûÀÎ ½ÃÀåÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ»ç±â ÆßÇÁ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ °ü¸®¿¡¼­ Á¤È®ÇÑ ¾à¹°Àü´Þ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿Ü·¡ ¹× ÀçÅà ġ·á ¼­ºñ½º Áõ°¡, ÆßÇÁÀÇ Áö´É°ú ¾ÈÀü¼º¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÁßȯÀÚ½Ç ÀÔ½Ç Áõ°¡¿Í ¼Ò¾Æ-½Å»ý¾Æ Ä¡·á½ÇÀÇ È®´ë·Î º´¿ø¿¡¼­ ÁÖ»ç±â ÆßÇÁ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

EMR ¹× ½º¸¶Æ® º´¿ø ÀÎÇÁ¶ó¿ÍÀÇ ±â¼ú ÅëÇÕÀ» ÅëÇØ µðÁöÅÐÈ­°¡ ¼º¼÷ÇÑ ÀÇ·á ½Ã½ºÅÛ¿¡¼­ äÅÃÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­, ¿þ¾î·¯ºí, ¹èÅ͸® ±¸µ¿½Ä ÆßÇÁ·ÎÀÇ ÀüȯÀº ÀçÅÃÄ¡·á ¹× ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­ÀÇ Á¢±Ù¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ö¾× ¾ÈÀü¿¡ ´ëÇÑ ±ÔÁ¦°¡ °­È­µÊ¿¡ µû¶ó ÀÇ·á½Ã¼³Àº ±âº»Çü¿¡¼­ ÷´Ü ÇÁ·Î±×·¡¹ÖÀÌ °¡´ÉÇÑ Á¦Ç°À¸·Î ¾÷±×·¹À̵åÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(ÁÖÀÔ ÆßÇÁ, ÈíÀÎ ÆßÇÁ); ¿ëµµ(ICU ¿ëµµ, ½ÉÀå ¼ö¼ú À¯´Ö ¿ëµµ, ¼Ò¾Æ°ú À¯´Ö ¿ëµµ, ¼ö¼ú½Ç ¿ëµµ); ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤Áø·á¼Ò ÃÖÁ¾ ¿ëµµ, ¿Ü·¡ Áø·á ½Ã¼³ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Syringe Pumps Market to Reach US$32.6 Billion by 2030

The global market for Syringe Pumps estimated at US$24.0 Billion in the year 2024, is expected to reach US$32.6 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Infusion Pump, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$21.4 Billion by the end of the analysis period. Growth in the Withdrawal Pump segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 8.5% CAGR

The Syringe Pumps market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Syringe Pumps Market - Key Trends & Drivers Summarized

Why Are Syringe Pumps Becoming Indispensable Across Healthcare Settings?

Syringe pumps are precision medical devices used to deliver small, controlled amounts of fluids, medications, or nutrients over set periods of time. These devices are critical in intensive care units, neonatal and pediatric settings, oncology wards, and pain management protocols. Their ability to provide consistent, programmable drug delivery makes them vital for high-risk treatments involving potent or narrow-therapeutic-window drugs.

As the prevalence of chronic diseases rises and hospital care becomes increasingly protocol-driven, syringe pumps are being adopted across a wider range of medical departments. Their utility in intravenous (IV) antibiotic administration, chemotherapy, and anesthesia makes them foundational to modern infusion therapy. Moreover, with the growing shift toward ambulatory care and home infusion services, demand is expanding for compact, portable syringe pump models that ensure patient mobility without compromising treatment precision.

How Is Innovation Enhancing the Safety and Intelligence of Syringe Pump Systems?

Modern syringe pumps are now equipped with advanced safety features such as dose error reduction systems (DERS), anti-bolus functions, air-in-line detection, and programmable lockouts. Integration with hospital electronic medical records (EMRs) and infusion management platforms allows for closed-loop medication administration, improving traceability and reducing human error.

Wireless connectivity and touch-screen interfaces are improving user interaction and remote monitoring capabilities. Smart pumps capable of integrating with pharmacy databases and clinical protocols are being deployed to ensure correct dosage and reduce adverse drug events. In high-acuity environments, syringe pumps are being linked to patient monitoring systems to provide real-time infusion feedback and automated alarms. These technological improvements are making syringe pumps not only more intelligent but also more central to clinical safety workflows.

Where Is Syringe Pump Usage Expanding Beyond Traditional Environments?

Beyond hospitals and clinics, syringe pumps are gaining traction in ambulatory infusion centers, emergency transport services, and home care programs. Patients undergoing long-term treatments such as palliative care, hormone therapy, and antimicrobial infusions are increasingly using portable pumps under professional supervision at home.

Veterinary medicine, academic research labs, and biotechnology facilities also employ syringe pumps for precise fluid control in experiments and drug delivery trials. In developing countries, governments and NGOs are deploying syringe pumps in mobile health units and rural hospitals to support maternal care, pediatric vaccinations, and infectious disease treatment. These diverse applications are creating a multi-dimensional market with both high-volume and specialized product demand.

The Growth in the Syringe Pumps Market Is Driven by Several Factors…

It is driven by increasing demand for precise drug delivery in chronic disease management, the rise in ambulatory and home care services, and ongoing innovation in pump intelligence and safety. Growing ICU admissions and expansion of pediatric and neonatal care units are elevating hospital-based syringe pump use.

Technological integration with EMRs and smart hospital infrastructure is enhancing adoption in digitally mature healthcare systems. The shift toward miniaturized, wearable, and battery-operated pumps is expanding access in home-based care and resource-limited environments. Furthermore, increasing regulatory focus on infusion safety is prompting healthcare facilities to upgrade from basic to advanced programmable syringe pumps.

SCOPE OF STUDY:

The report analyzes the Syringe Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Infusion Pump, Withdrawal Pump); Application (ICU Application, Cardiac Surgery Units Application, Pediatric Units Application, Operating Theatres Application); End-Use (Hospitals & Clinics End-Use, Ambulatory Care Settings End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â